NIH-funded research R01 grant

Investigating how YAP signaling affects liver disease in people with HIV

Official title: YAP signaling in the pathogenesis of NAFLD in people living with HIV

Funded at Massachusetts General Hospital · NIH-10931742 · Data updated 2026-11-12

This study is looking at how a specific signaling process in the liver affects people with HIV who have nonalcoholic fatty liver disease, with the goal of finding new ways to help improve liver health for those living with this condition.

More NAFLD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 26, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$780,234
NIH project number5R01DK138474-02
Project IDNIH-10931742 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults living with HIV who are experiencing or at risk for nonalcoholic fatty liver disease.

Less likely to help

Patients who do not have HIV or those without liver disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of YAP signaling in the development of nonalcoholic fatty liver disease (NAFLD) among individuals living with HIV. It aims to explore the mechanisms behind the high prevalence of liver disease in this population, particularly how HIV influences liver fibrosis and inflammation. By studying the Hippo signaling pathway and its impact on liver cells, the research seeks to identify potential therapeutic targets that could improve liver health in patients with HIV. The approach includes both human studies and animal models to validate findings.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve liver health and reduce complications for people living with HIV.

How similar studies have gone: Previous research has shown promising results in understanding liver disease mechanisms in HIV, but this specific approach focusing on YAP signaling is relatively novel.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Chung, Raymond T — Massachusetts General Hospital
  • Study coordinator: Chung, Raymond T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.